Commentary
Commentary
Read about the bill in Congress that would ban the use of "quality-adjusted life years"
Congress needs to cut QALYs
The House of Representatives last week approved a bill that would ban the use of “quality-adjusted life years,” or QALYs, as well as other measures for determining the purported value of a medical intervention, in all federal health programs. Now the Senate will consider the measure. QALYs should have no place in federal decision-making about whether ...
Commentary
Read the latest on Medicare's prescription drug price-setting scheme
Can Constitution Save Us from Drug Price Controls?
AstraZeneca made its case against Medicare’s prescription drug price-setting scheme before a federal judge in Delaware last week. It’s one of several drugmakers challenging the program on constitutional grounds, among them Johnson & Johnson, Merck and Bristol Myers Squibb. Defenders of the price control plan have portrayed these cases as the machinations of money-grubbing ...
Commentary
Reforming PBMs Improves the Drug Market and Thwarts Efforts to Socialize Medicine
By Sally Pipes & Wayne Winegarden There they go again. Free-market advocates are jeopardizing pro-market healthcare reforms based on an inability to recognize how cronyism tars the current industry dynamics. That distinction between companies operating in a free market and companies using cronyism to flourish in a government-dominated market is ...
Commentary
Read the latest on Florida's drug importation plan
Is the FDA opening a door for counterfeit drug trade?
The U.S. Food and Drug Administration gave the go-ahead last month for Florida to import prescription drugs in bulk from Canada. If all goes according to plan, the state government will be able to dispense certain Canadian-sourced drugs to people who receive care through the state Department of Corrections, the ...
Commentary
Americans Want Value for Healthcare, Not Another Welfare Plan
Obamacare’s insurance marketplaces are doing a brisk business. According to federal data released last month, a record 21.3 million Americans signed up for an exchange plan during the 2024 open enrollment season. Nearly 5 million were new customers. “Numbers do not lie,” said Chiquita Brooks-LaSure, administrator of the Centers for Medicare and Medicaid ...
Business & Economics
Read the latest on the federal PRO Act
California’s War On Gig Work Is About To Devastate The Rest Of The Country
Like wreckage following a tornado, California’s effort to eliminate gig work trailed Julie Su as she failed upward from the state’s Labor and Workforce Development Agency secretary to Washington, where she’s the acting labor secretary. In her previous capacity, Su was a hardline supporter of California’s Assembly Bill 5, which ...
Commentary
This Policy Helped Make COVID Vaccines Possible. It Could Soon Disappear.
If you’re among the 81% of Americans who have been vaccinated against COVID-19, you probably remember your first dose. Perhaps you snapped a selfie on your way out of the vaccine clinic. California Sen. Alex Padilla took things a step further and shared a video on Facebook encouraging his constituents to get the jab. ...
California
Read the latest on Project Homekey
Latest figures show what we’ve known all along: Project Homekey is a waste of taxpayer dollars
Recently, the Bay Area media wondered if $800 million in aid from California’s Homekey program would help reduce homelessness in the region. Not to diminish the work that was put into the analysis, but some of us have known for quite a while that Project Homekey was not the answer. ...
Commentary
Read the latest on prescription drug pricing
Bernie’s Anti-Pharma Crusade Is Not In Patients’ Interests
Next week, the Senate Health, Education, Labor, and Pensions Committee will convene to hear testimony from the CEOs of Johnson & Johnson, Merck, and Bristol Myers Squibb on the prices of their drugs. The executives agreed to testify after the committee’s chair, Vermont socialist Sen. Bernie Sanders, I-Vt., threatened to ...
Commentary
Calling Out The ESG Bait And Switch
The bait and switch that Environmental, Social, and Governance (ESG) activists have been peddling for too long is coming into focus. Activist investors claim they submit ESG proposals at annual meetings to improve corporate profitability. All too often, these proposals are attempts to hijack the corporate governance process to implement ...
Read about the bill in Congress that would ban the use of "quality-adjusted life years"
Congress needs to cut QALYs
The House of Representatives last week approved a bill that would ban the use of “quality-adjusted life years,” or QALYs, as well as other measures for determining the purported value of a medical intervention, in all federal health programs. Now the Senate will consider the measure. QALYs should have no place in federal decision-making about whether ...
Read the latest on Medicare's prescription drug price-setting scheme
Can Constitution Save Us from Drug Price Controls?
AstraZeneca made its case against Medicare’s prescription drug price-setting scheme before a federal judge in Delaware last week. It’s one of several drugmakers challenging the program on constitutional grounds, among them Johnson & Johnson, Merck and Bristol Myers Squibb. Defenders of the price control plan have portrayed these cases as the machinations of money-grubbing ...
Reforming PBMs Improves the Drug Market and Thwarts Efforts to Socialize Medicine
By Sally Pipes & Wayne Winegarden There they go again. Free-market advocates are jeopardizing pro-market healthcare reforms based on an inability to recognize how cronyism tars the current industry dynamics. That distinction between companies operating in a free market and companies using cronyism to flourish in a government-dominated market is ...
Read the latest on Florida's drug importation plan
Is the FDA opening a door for counterfeit drug trade?
The U.S. Food and Drug Administration gave the go-ahead last month for Florida to import prescription drugs in bulk from Canada. If all goes according to plan, the state government will be able to dispense certain Canadian-sourced drugs to people who receive care through the state Department of Corrections, the ...
Americans Want Value for Healthcare, Not Another Welfare Plan
Obamacare’s insurance marketplaces are doing a brisk business. According to federal data released last month, a record 21.3 million Americans signed up for an exchange plan during the 2024 open enrollment season. Nearly 5 million were new customers. “Numbers do not lie,” said Chiquita Brooks-LaSure, administrator of the Centers for Medicare and Medicaid ...
Read the latest on the federal PRO Act
California’s War On Gig Work Is About To Devastate The Rest Of The Country
Like wreckage following a tornado, California’s effort to eliminate gig work trailed Julie Su as she failed upward from the state’s Labor and Workforce Development Agency secretary to Washington, where she’s the acting labor secretary. In her previous capacity, Su was a hardline supporter of California’s Assembly Bill 5, which ...
This Policy Helped Make COVID Vaccines Possible. It Could Soon Disappear.
If you’re among the 81% of Americans who have been vaccinated against COVID-19, you probably remember your first dose. Perhaps you snapped a selfie on your way out of the vaccine clinic. California Sen. Alex Padilla took things a step further and shared a video on Facebook encouraging his constituents to get the jab. ...
Read the latest on Project Homekey
Latest figures show what we’ve known all along: Project Homekey is a waste of taxpayer dollars
Recently, the Bay Area media wondered if $800 million in aid from California’s Homekey program would help reduce homelessness in the region. Not to diminish the work that was put into the analysis, but some of us have known for quite a while that Project Homekey was not the answer. ...
Read the latest on prescription drug pricing
Bernie’s Anti-Pharma Crusade Is Not In Patients’ Interests
Next week, the Senate Health, Education, Labor, and Pensions Committee will convene to hear testimony from the CEOs of Johnson & Johnson, Merck, and Bristol Myers Squibb on the prices of their drugs. The executives agreed to testify after the committee’s chair, Vermont socialist Sen. Bernie Sanders, I-Vt., threatened to ...
Calling Out The ESG Bait And Switch
The bait and switch that Environmental, Social, and Governance (ESG) activists have been peddling for too long is coming into focus. Activist investors claim they submit ESG proposals at annual meetings to improve corporate profitability. All too often, these proposals are attempts to hijack the corporate governance process to implement ...
